U.S. markets closed

Target Group Inc. (CBDY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0075-0.0005 (-6.25%)
At close: 11:11AM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0080
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0065 - 0.0077
52 Week Range0.0030 - 0.0270
Avg. Volume81,351
Market Cap4.628M
Beta (5Y Monthly)-1.45
PE Ratio (TTM)0.75
EPS (TTM)0.0100
Earnings DateAug 13, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for CBDY

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: Integra Lifesciences Hldgs CorBased in Plainsboro, New Jersey, Integra is an integrated medical device company that develops and markets devices for use in neurosurgery and wound repair. The company's products are used in cranial and spinal procedures, peripheral nerve repair, the repair of skin and deeper tissue from burns and vehicular accidents, and the repair and reconstruction of soft tissue. It operates in two segments: Codman Specialty Surgical, and Tissue Technologies. The company also markets products through private-label relationships with other medical device companies.
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more
  • CNW Group

    Canary RX Announces Year to Date Wholesale Cannabis Sales

    Target Group Inc. (OTCQB: CBDY) is pleased to announce that its wholly owned subsidiary, Canary Rx Inc. ("Canary" or the "Company") has successfully fulfilled approximately 665 kgs of craft cannabis valued at over 1.9 million dollars wholesale.

  • CNW Group

    Canary RX Receives its Health Canada Sales License

    Target Group Inc. (OTCQB: CBDY) is pleased to announce that its wholly owned subsidiary, Canary Rx Inc. ("Canary" or the "Company") has received its Health Canada sales license.